No Data
Geron Q3 2024 Earnings Preview
H.C. Wainwright Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $8
Geron Announces New Data To Be Presented Highlighting The Potential Of RYTELO In Myeloid Hematologic Malignancies At Upcoming ASH Annual Meeting
H.C. Wainwright Initiates Geron(GERN.US) With Buy Rating, Announces Target Price $8
Express News | Geron Corporation : H.c. Wainwright Initiates Coverage With Buy Rating
Earnings Preview: Geron to Report Financial Results Pre-market on November 07
$Geron(GERN.US)$ is scheduled to release its financial results pre-market on November 07 ET. Earnings PreviewAnalysts estimate $Geron(GERN.US)$ to post revenue of USD18.97M for 2024Q3, up 11464.94%
No Data
No Data